How often are pregnancy tests required during and after thalidomide treatment for women of childbearing potential without confirmed tubal sterilisation?

Women of childbearing potential without confirmed tubal sterilisation, including those practising abstinence, require medically supervised pregnancy tests every 4 weeks during thalidomide treatment and 4 weeks after treatment ends, on the prescribing visit day or within the preceding 3 days.